Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intraductal Carcinoma and Lobular Carcinoma in Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03664778
What this trial is testing

Abbreviated Breast MRI After Cancer Treatment

Who this might be right for
Breast NeoplasmsCarcinoma, Intraductal, Noninfiltrating
University of Pennsylvania 184
Not applicableStudy completedNCT00605982
What this trial is testing

Breast MRI as a Preoperative Tool for DCIS

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Memorial Sloan Kettering Cancer Center 115
Not applicableStudy completedNCT00898508
What this trial is testing

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Who this might be right for
Breast Cancer
City of Hope Medical Center 563
Not applicableActive Not RecruitingNCT04916808
What this trial is testing

The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing

Who this might be right for
DCIS
PreludeDx 1,500
Not applicableUnknownNCT00671476
What this trial is testing

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Who this might be right for
Breast Cancer
Dr. Susan Love Research Foundation 30
Not applicableActive Not RecruitingNCT03495011
What this trial is testing

MRI Characterization of Mammographically Detected DCIS

Who this might be right for
Breast Cancer, Stage 0
University of Washington 122
Not applicableLooking for participantsNCT04543799
What this trial is testing

Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer

Who this might be right for
Prostate CancerBreast Cancer
Oncology Institute of Southern Switzerland 60
Not applicableStudy completedNCT01874184
What this trial is testing

Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaAtypical Lobular Breast HyperplasiaBRCA1 Mutation Carrier+3 more
University of Washington 17
Testing effectiveness (Phase 2)Study completedNCT02928978
What this trial is testing

Ruxolitinib for Premalignant Breast Disease

Who this might be right for
Ductal Carcinoma In SituAtypical Lobular HyperplasiaAtypical Ductal Hyperplasia+1 more
Julie Nangia 84
Not applicableNot Yet RecruitingNCT07544134
What this trial is testing

Areola Preservation in NSM With Nipple Involvement

Who this might be right for
Breast CancerDuctal Carcinoma In Situ, DCISInvasive Breast Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)Ended earlyNCT01372618
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor

Who this might be right for
Ductal Carcinoma in Situ
NYU Langone Health 9
Not applicableStudy completedNCT01132560
What this trial is testing

Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ

Who this might be right for
Breast Cancer
ECOG-ACRIN Cancer Research Group 500
Not applicableStudy completedNCT03437161
What this trial is testing

A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation

Who this might be right for
Breast Cancer
NYU Langone Health 40
Large-scale testing (Phase 3)Study completedNCT01112254
What this trial is testing

Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 360
Not applicableLooking for participantsNCT03448926
What this trial is testing

The PREDICT Registry:

Who this might be right for
DCISStage 0 Breast CancerDuctal Breast Carcinoma In Situ
PreludeDx 3,000
Not applicableStudy completedNCT00388115
What this trial is testing

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, Davis 15
Testing effectiveness (Phase 2)Study completedNCT03931928
What this trial is testing

Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients

Who this might be right for
Breast CancerDCIS
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) 356
Testing effectiveness (Phase 2)Study completedNCT02636582
What this trial is testing

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In Situ
National Cancer Institute (NCI) 43
Not applicableWithdrawnNCT03868475
What this trial is testing

Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions

Who this might be right for
Breast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not applicableNot Yet RecruitingNCT07245316
What this trial is testing

Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial

Who this might be right for
Ductal Carcinoma in Situ of the Breast
Jeong Eon Lee 340
Next Page